Xeris Biopharma Holdings (NASDAQ:XERS) is set to present an overview at the 42nd Annual JP Morgan Healthcare Conference on January 11, 2024, at 12 pm Pacific Time.
The presentation by Paul R. Edick, Xeris' Chairman and CEO, will be accessible via the "Events" section on the investor relations page of the company's website: www.xerispharma.com.
The growth-oriented biopharmaceutical company focuses on enhancing patients' lives through innovative product development across various therapies.